First Aid Beauty Body Acne Clearing Mist

Description

First Aid Beauty BODY ACNE CLEARING MIST is formulated specifically for the treatment of acne, featuring 2% Salicylic Acid as its active ingredient. This product is designed to be safe for sensitive skin, providing an effective solution for body acne. The mist is packaged in a 88.7 mL (3 FL OZ) container, ensuring convenient application.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to application of the product. The recommended administration involves spraying the product over the affected areas of the chest and back. Initial dosing should consist of one application daily. If necessary, and as directed by a physician, the frequency may be gradually increased to two applications daily.

It is important to monitor for excessive drying of the skin, which may occur with use. In the event that bothersome dryness or peeling is experienced, the frequency of application should be reduced to once daily or every other day, based on the patient's tolerance and response to treatment.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. The application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. To minimize the risk of irritation, it is recommended that only one topical acne medication be utilized at a time.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Direct spraying of the product onto the face is contraindicated. Care should be taken to avoid contact with the eyes; should contact occur, the affected area must be rinsed thoroughly with water. If skin irritation develops, the use of the product should be discontinued. This product is not intended for use in children under 3 years of age.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised that only one topical acne medication be utilized at a time to minimize the risk of irritation.

In the event of contact with the eyes, patients should rinse thoroughly with water. Should skin irritation develop, discontinuation of use is recommended. This product is not intended for use in children under 3 years of age.

Additionally, it is crucial to keep this product out of reach of children. If ingested, patients should seek medical assistance or contact a Poison Control Center immediately.

This product is for external use only.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of First Aid Beauty Body Acne Clearing Mist (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 3 years of age should not use this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been established. There are no available data regarding the potential risks or fetal outcomes associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to discuss the potential risks and benefits with their patients. It is recommended that healthcare providers remain vigilant and informed about any emerging data related to the use of this medication in pregnant patients.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, the use of this medication in lactating mothers and its effects on breastfed infants remain unspecified. Healthcare professionals should exercise clinical judgment when prescribing this medication to lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous evaluation of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important for healthcare providers to discuss the potential for skin irritation and dryness associated with the use of this medication. Patients should be informed that the likelihood of experiencing these side effects may increase if they are using another topical acne medication concurrently. Therefore, if irritation occurs, patients should be counseled to use only one topical acne medication at a time to minimize the risk of adverse effects.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is protected from light exposure to maintain its integrity. Freezing the product is strictly prohibited, as it may compromise its effectiveness. Additionally, the container must be kept upright to prevent any potential leakage or contamination. Proper adherence to these storage and handling guidelines is crucial for preserving the quality of the product.

Additional Clinical Information

The product is administered topically, with a recommended application of 1 to 2 sprays over the affected areas of the chest and back once or twice daily. Patients should begin with one application daily and may increase to two applications as needed or as directed by a healthcare professional.

Clinicians should counsel patients that the product is for external use only and advise against simultaneous use with other topical acne medications to minimize the risk of skin irritation and dryness. It is important to keep the product out of reach of children, and in the event of ingestion, medical assistance should be sought immediately. Patients should avoid spraying the product directly on the face and ensure it does not come into contact with the eyes; if contact occurs, they should rinse with water. The product is not recommended for children under 3 years of age, and if skin irritation develops, use should be discontinued.

Drug Information (PDF)

This file contains official product information for First Aid Beauty Body Acne Clearing Mist, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)